Bausch Health Companies | VRX - Capital Ordinário





Capital Ordinário Alterar Data
Amgen USD 541M 1000K 2026-06
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Bausch Health Companies USD 373.9M 436K 2026-06
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Danaher USD 703.4M 500K 2026-09
Drreddys Laboratories INR 832.69M 123K 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novo Nordisk DKK 4.43B 13.25M 2026-06
Pacira USD 39.82M 512K 2026-06
Perrigo USD 138.1M 500K 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.37M 53K 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Vertex Pharmaceuticals USD 253.3M 900K 2026-06
Zoetis USD 414.15M 6.19M 2026-06